Biocon opens book for Syngene IPO

Indian pharma company spins off contract research arm, hoping markets will regain a solid footing after Monday's sharp fall.

Biocon opens book for Syngene IPO

Indian pharma company Biocon launched a Rs5.28 billion to Rs5.5 billion $82.2 million to $85.7 million initial public offering in its clinical research arm Syngene International on Monday.

The deal had seemed well-timed, taking advantage of a stock market rally, which began in mid-June. The company will now be hoping Monday's sharp fall does not presage a new downswing.

The Sensex suffered its biggest one-day drop in two months yesterday, closing down...

To continue reading, please login or register for free

Click for more on: india | credit suisse | jefferies | axis capital | equity | ipo | pharma

Print Edition

FinanceAsia Print Edition


  • Green Bonds Southeast Asia

    25 May 2017  |  Singapore
    With Green Bonds globally reaching USD200 billion outstanding in 2016, from as little as 30bn just 4 years ago, can SE Asia corporations and ...
  • 2nd Compliance Summit Southeast Asia

    17 August 2017  |  Singapore
    The 2017 Compliance Summit Southeast Asia will take an in-depth look at the key compliance considerations today with a focus on regulation and new ...